ArticleFrontiers in pharmacology2022

Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of CMAB807, a New Denosumab Biosimilar, in Healthy Chinese Subjects.

Hanjing Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.